<DOC>
	<DOCNO>NCT02346838</DOCNO>
	<brief_summary>Forty-eight prediabetic men woman ( 50-75 year age ) participate 6-week feeding study randomize receive either 10 g/day inulin placebo . All subject feed isocaloric diet ( 50 % carbohydrate , 35 % fat , 15 % protein , ) control micronutrient content 6 week avoid potential confound individual difference diet gut microbiota . Measurements intestinal permeability , insulin sensitivity , skeletal muscle metabolic flexibility make prior follow control feeding period . Stool sample collect assess gut microbial community .</brief_summary>
	<brief_title>Prebiotics , Gut Microbiota , Cardiometabolic Health</brief_title>
	<detailed_description>Prebiotics define `` selectively fermented ingredient result specific change composition and/or activity gastrointestinal microbiota , thus confer health benefit ( ) upon host health '' . Commonly used prebiotics inulin-type fructans , fructo-oligosaccharides , xylo-oligosaccharides galacto-oligosaccharides prebiotics fiber , fiber prebiotics . The proliferation target bacterial specie , particular , Bifiodobacterium spp . Lactobacillus spp . contribute host cardiometabolic health many way include , limited , short chain fatty acid production , modulation gut barrier function , endotoxin concentration , inflammatory pathway , energy metabolism however , knowledge potential benefit prebiotic supplementation cardiometabolic dysfunction receive little attention . Although concept dysbiosis gut microbiota lead metabolic endotoxemia increase risk cardiometabolic disease novel , little information available human . The significance proposal include provide proof concept efficacy prebiotic supplementation inulin cardiometabolic dysfunction assess relation change gut bacterial community , intestinal permeability , metabolic endotoxemia prediabetes , condition affect substantial segment population . Our study could lead identification prebiotic supplementation inulin simple efficacious strategy reduce cardiometabolic risk prediabetes could change clinical practice inform dietary recommendation increase acceptance prebiotics scientific medical community .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<criteria>Men woman ; postmenopausal woman take hormone replacement therapy . Fasting glucose 5.6 6.9 mmol/L and/or 2h plasma glucose 7.811.1 mmol/L follow 75 g oral glucose tolerance test . Weight stable previous 6 month ( +/ 2.0 kg ) . Sedentary recreationally active Willing randomize treatment placebo . Verbal write informed consent . No plan gain/lose weight change physical activity level . Willing pick food daily , consume food provide 6week controlled feeding period . BMI le 25 kg/m2 great 40 kg/m2 body mass great 300 pound due limit DEXA . Diabetes diabetes medication Prebiotic probiotic supplement product consumption prior 3 month . Total cholesterol &gt; 6.2 mmol/L ; triglyceride &gt; 4.5 mmol/L . Blood pressure &gt; 140/90 mmHg antihypertensive medication . Diagnosed inflammatory disease ( e.g . lupus , irritable bowel , periodontal disease , etc ) Fructo , galacto , xylooligosaccharide intake &gt; 3 g/day . Past current ischemic heart disease , stroke , respiratory disease , endocrine metabolic disease , neurological disease , hematologicaloncological disease . Smoking , alcohol consumption &gt; 2 serving /d male 1 serving/d female , take medication ( include limit statin drug antiinflammatory action ) antioxidant vitamins supplement . Known allergy , hypersensitivity , intolerance inulin .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Prediabetes , prebiotics , metabolic endotoxemia</keyword>
</DOC>